The etiology of multiple sclerosis (MS) is complex, involving genetic and environmental risk factors and their interactions. Furthermore, evidence suggests that the timing of exposure to environmental factors may be important. The exploration of risk associated with exposures distant in time, e.g., in childhood, or even before birth, presents particular difficulties. For example, month of birth has been considered a proxy for early-life vitamin D status. Thus, the finding that people with MS are more likely to have been born in spring and less likely to have been born in autumn in both southern and northern hemispheres (reviewed in reference 1) has been interpreted as possibly indicating that early-life vitamin D deficiency increases the risk of MS in adulthood. Determining any change in risk associated with other in utero exposures has been more challenging because of a lack of suitable validated proxies and a need to rely on self-reported events that occurred many years previously, during the pregnancy of the patient's mother. For example, in the Nurses' Health Studies, late initiation of prenatal care, diabetes during pregnancy, and maternal prepregnancy overweight/obesity were associated with modest increases in MS risk, although in most instances, the number of affected persons was small.
Do prenatal sex hormones modulate MS risk?
The etiology of multiple sclerosis (MS) is complex, involving genetic and environmental risk factors and their interactions. Furthermore, evidence suggests that the timing of exposure to environmental factors may be important. The exploration of risk associated with exposures distant in time, e.g., in childhood, or even before birth, presents particular difficulties. For example, month of birth has been considered a proxy for early-life vitamin D status. Thus, the finding that people with MS are more likely to have been born in spring and less likely to have been born in autumn in both southern and northern hemispheres (reviewed in reference 1) has been interpreted as possibly indicating that early-life vitamin D deficiency increases the risk of MS in adulthood. Determining any change in risk associated with other in utero exposures has been more challenging because of a lack of suitable validated proxies and a need to rely on self-reported events that occurred many years previously, during the pregnancy of the patient's mother. For example, in the Nurses' Health Studies, late initiation of prenatal care, diabetes during pregnancy, and maternal prepregnancy overweight/obesity were associated with modest increases in MS risk, although in most instances, the number of affected persons was small. 2 In this issue of Neurology ® , Bove et al. 3 report that the ratio of the length of the second digit to that of the fourth digit (2D:4D), a presumed proxy for in utero exposure to androgens, was associated with MS risk. Genetic control of the differentiation of both the digits and the gonads is through the Hox genes 4 and sexual dimorphism in the 2D:4D ratio, i.e., ,1 in males (i.e., the fourth digit is longer than the second) and $1 in females, provides a link between digit development and sex hormone exposure. 4 Bove et al. found that men with MS (n 5 138) had a higher median 2D:4D ratio than men without autoimmune or endocrine diseases (n 5 145). Since the 2D:4D ratio appears to be stable through life from around 2 years of age, including during puberty, 4 it provides a window on the early origins of disease risk associated with the level of exposure to sex hormones. The results from Bove et al. 3 would suggest that lower androgen exposure during gestation was associated with increased MS risk. There are racial differences in the 2D:4D ratio, but the association with MS risk seen in this study persisted when the analyses were restricted to white participants only. Digits were assigned the mean value of the longest length, as measured on digital images using calipers, assigned independently by 2 researchers blinded to the MS status of the participant. There was good agreement between the duplicate measurements. Of note, the testosterone levels in the men with MS were not significantly different from those of controls, in contrast to recent studies that have linked low testosterone levels in adulthood to increased MS risk and higher disability. 5 However, if risk is determined in childhood, then adult hormonal levels may not be relevant as determinants of risk. Testosterone and estriol have also been used as treatment in MS, with some evidence that testosterone treatment has neuroprotective effects and increases cerebral gray matter. 6 However, factors that influence risk may or may not also influence disease activity.
There is some evidence for a specific association between 2D:4D ratio and exposure to fetal androgens. Allelic variation in the androgen receptor that results in greater insensitivity to androgens is associated with a higher (less masculine) 2D:4D ratio, 7 and, of interest, a range of genetic neuronopathies. 8 In addition, children with congenital adrenal hyperplasia who have high gestational exposure to androgens have lower 2D:4D ratios than controls, at least in the right hand. 7 A number of studies show a correlation between a lower 2D:4D ratio and behavioral traits that are recognized as being more "masculine," e.g., higher trait physical aggression. 7 Recent evidence, however, challenges the specificity of 2D:4D ratio as a proxy for androgen exposure during pregnancy and suggests that the relationship with prenatal sex steroids is more complex, reflecting the balance of fetal testosterone and fetal estrogen (reviewed in reference 7). In a recent genome-wide association study, the strongest association with 2D:4D ratio was with a single variant in the LIN28B gene, but the association of this gene with height and delayed menarche was in the opposite direction to that previously reported for 2D:4D ratio. 9 Furthermore, in one small study (n 5 33), there was no association between amniotic fluid testosterone levels (at approximately 17 weeks' gestation) and the 2D:4D ratio at 24 months. There was, however, a correlation between the 2D:4D ratio and the ratio of fetal testosterone to estradiol. 7 Exposure to prenatal androgens has long-lasting effects on development of both the brain and the immune system. For example, variations in fetal testosterone measured from amniocentesis samples (at 13-20 weeks' gestation) predicted local gray matter volume in specific brain regions (on MRI) in boys at ages 8 to 11 years. 10 Data regarding effects on the immune system in humans are not available, but in avian studies, zebra finches hatching from eggs that had experimentally elevated testosterone levels had enhanced primary and secondary humoral immune responses toward diphtheria and tetanus antigens and an alteration in the balance of humoral and cell-mediated immunity.
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Our measures and proxies of androgen exposure in utero are, to date, crude and largely nonspecific. We are unable to examine potential critical periods of exposure when neural structures or immune system parameters are being established. The research by Bove et al. strengthens the evidence that MS susceptibility is determined at least in part by exposures occurring in utero. In the absence of good animal models, it remains particularly challenging to define and quantify the risks and specific periods of risk, and thus whether monitoring and intervention are feasible or useful.
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